MetaCap

Prime Medicine Earnings

NASDAQ: PRMEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

3.99+0.41 (+11.45%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Fri, Nov 6, 2026

Fiscal period

Sep/2026

EPS estimate

$-0.23

Prime Medicine earnings summary

Prime Medicine is scheduled to report Sep/2026 earnings on Nov 6, 2026, with analysts expecting EPS of $-0.23.

Summary generated from market data by MetaCap's automated system. Methodology

Related